Tissue-based class control: The other side of tolerance

Nature Reviews Immunology

Volumn 11, Issue 3, 2011, Pages 221-230

  Matzinger, Polly ^a   Kamala, Tirumalai ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ALPHA INTERMEDIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; ORAL POLIOMYELITIS VACCINE; RABIES VACCINE; THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR 5; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADAPTIVE IMMUNITY; ALLERGY; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HELPER CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOTHERAPY; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; VACCINATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNITY; MODELS, IMMUNOLOGICAL; NEUROIMMUNOMODULATION; ORGAN SPECIFICITY; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; TIME FACTORS; VACCINATION;

EID: 79952126441     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2940     Document Type: Article

References (151)

1. Streilein, J. W. Pathologic lesions of GVH disease in hamsters: antigenic target versus 'innocent bystander'. Prog. Exp. Tumor Res. 16, 396-408 (1972).
2. Elson, C. O., Reilly, R. W. & Rosenberg, I. H. Small intestinal injury in the graft versus host reaction: an innocent bystander phenomenon. Gastroenterology 72, 886-889 (1977). (Pubitemid 8093899)
3. Krook, H. et al. A distinct Th1 immune response precedes the described Th2 response in islet xenograft rejection. Diabetes 51, 79-86 (2002). (Pubitemid 34517983)
4. Knisely, T. L., Luckenbach, M. W., Fischer, B. J. & Niederkorn, J. Y. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors. J. Immunol. 138, 4515-4523 (1987). (Pubitemid 17090435)
5. Abram, M. et al. Effects of pregnancy-associated Listeria monocytogenes infection: necrotizing hepatitis due to impaired maternal immune response and significantly increased abortion rate. Virchows Arch. 441, 368-379 (2002). (Pubitemid 36015600)
6. Seong, S. Y. & Matzinger, P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nature Rev. Immunol. 4, 469-478 (2004). (Pubitemid 38745558)
7. Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature Immunol. 11, 373-384 (2010).
8. Zhang, Q. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-107 (2010).
9. Dowling, D. J. et al. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses. Infect. Immun. 78, 793-801 (2010).
10. Koch, A. L. Bacterial wall as target for attack: past, present, and future research. Clin. Microbiol. Rev. 16, 673-687 (2003). (Pubitemid 37296555)
11. Andersen-Nissen, E. et al. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc. Natl Acad. Sci. USA 102, 9247-9252 (2005). (Pubitemid 40923549)
12. Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045 (1994).
13. Matzinger, P. The danger model: a renewed sense of self. Science 296, 301-305 (2002). (Pubitemid 34303674)
14. Matzinger, P. Friendly and dangerous signals: is the tissue in control? Nature Immunol. 8, 11-13 (2007). (Pubitemid 46242350)
15. Kelso, A. Th1 and Th2 subsets: paradigms lost? Immunol. Today 16, 374-379 (1995).
16. O'Shea, J. J. & Paul, W. E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098-1102 (2010).
17. Pulendran, B. et al. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 167, 5067-5076 (2001). (Pubitemid 33009740)
18. Yang, D. et al. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J. Exp. Med. 205, 79-90 (2008). (Pubitemid 351185717)
19. Prussin, C., Lee, J. & Foster, B. Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5-TH2 responses. J. Allergy Clin. Immunol. 124, 1326-1332 (2009).
20. Hume, D. M. & Egdahl, R. H. Progressive destruction of renal homografts isolated from the regional lymphatics of the host. Surgery 38, 194-214 (1955).
21. Medawar, P. B. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br. J. Exp. Pathol. 29, 58-69 (1948).
22. Barker, C. F. & Billingham, R. E. Immunologically privileged sites. Adv. Immunol. 25, 1-54 (1977).
23. Barker, C. F. & Billingham, R. E. The lymphatic status of hamster cheek pouch tissue in relation to its properties as a graft and as a graft site. J. Exp. Med. 133, 620-639 (1971).
24. Fijak, M. & Meinhardt, A. The testis in immune privilege. Immunol. Rev. 213, 66-81 (2006). (Pubitemid 44401494)
25. Ferguson, T. A. & Griffith, T. S. A vision of cell death: Fas ligand and immune privilege 10 years later. Immunol. Rev. 213, 228-238 (2006). (Pubitemid 44401504)
26. Caspi, R. R. Ocular autoimmunity: the price of privilege? Immunol. Rev. 213, 23-35 (2006). (Pubitemid 44401491)
27. Streilein, J. W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nature Rev. Immunol. 3, 879-889 (2003). (Pubitemid 37411717)
28. Niederkorn, J. Y. & Stein-Streilein, J. History and physiology of immune privilege. Ocul. Immunol. Inflamm. 18, 19-23 (2010).
29. Coffman, R. L., Lebman, D. A. & Shrader, B. Transforming growth factor β specifically enhances IgA production by lipopolysaccharide- stimulated murine B lymphocytes. J. Exp. Med. 170, 1039-1044 (1989). (Pubitemid 19226686)
30. Sonoda, E. et al. Transforming growth factor β induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 170, 1415-1420 (1989). (Pubitemid 19250703)
31. Boirivant, M. et al. Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytes. Gastroenterology 106, 576-582 (1994). (Pubitemid 24064321)
32. Kimata, H. & Fujimoto, M. Vasoactive intestinal peptide specifically induces human IgA1 and IgA2 production. Eur. J. Immunol. 24, 2262-2265 (1994). (Pubitemid 24276566)
33. Fang, Y., Yu, S., Ellis, J. S., Sharav, T. & Braley-Mullen, H. Comparison of sensitivity of Th1, Th2, and Th17 cells to Fas-mediated apoptosis. J. Leukoc. Biol. 87, 1019-1028 (2010).
34. Shinohara, M. L., Kim, J. H., Garcia, V. A. & Cantor, H. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 29, 68-78 (2008).
35. Khoury, S. J., Hancock, W. W. & Weiner, H. L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176, 1355-1364 (1992).
36. Miller, A., Lider, O., Roberts, A. B., Sporn, M. B. & Weiner, H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl Acad. Sci. USA 89, 421-425 (1992).
37. Scadding, G. & Durham, S. Mechanisms of sublingual immunotherapy. J. Asthma 46, 322-334 (2009).
38. Salk, D. & Salk, J. Vaccinology of poliomyelitis. Vaccine 2, 59-74 (1984). (Pubitemid 15167635)
39. Sterner, R. T., Meltzer, M. I., Shwiff, S. A. & Slate, D. Tactics and economics of wildlife oral rabies vaccination, Canada and the United States. Emerg. Infect. Dis. 15, 1176-1184 (2009).
40. Chen, Y. et al. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376, 177-180 (1995).
41. Alpan, O., Rudomen, G. & Matzinger, P. The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J. Immunol. 166, 4843-4852 (2001). (Pubitemid 32280692)
42. Mestecky, J., Russell, M. W. & Elson, C. O. Perspectives on mucosal vaccines: is mucosal tolerance a barrier? J. Immunol. 179, 5633-5638 (2007).
43. Maloy, K. J., Donachie, A. M., O'Hagan, D. T. & Mowat, A. M. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology 81, 661-667 (1994). (Pubitemid 24246520)
44. Weiner, H. L. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol. Rev. 182, 207-214 (2001). (Pubitemid 33070220)
45. Abreu, M. T. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nature Rev. Immunol. 10, 131-144 (2010).
46. Kaplan, H. J. & Niederkorn, J. Y. Regional immunity and immune privilege. Chem. Immunol. Allergy 92, 11-26 (2007). (Pubitemid 47096893)
47. Boehm, U., Klamp, T., Groot, M. & Howard, J. C. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15, 749-795 (1997).
48. Tracey, K. J. & Cerami, A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45, 491-503 (1994).
49. Kagi, D., Ledermann, B., Burki, K., Zinkernagel, R. M. & Hengartner, H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14, 207-232 (1996). (Pubitemid 26130183)
50. Mukaida, N. Antibody-dependent cell-mediated cytotoxicity (ADCC). Nippon Rinsho 57 (Suppl.), 571-573 (1999).
51. MacMicking, J., Xie, Q. W. & Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350 (1997). (Pubitemid 27169284)
52. Carroll, M. C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16, 545-568 (1998). (Pubitemid 28183376)
53. Chaouat, G. et al. TH1/TH2 paradigm in pregnancy: paradigm lost? Int. Arch. Allergy Immunol. 134, 93-119 (2004).
54. Linthicum, D. S., Mackay, I. R. & Carnegie, P. R. Measurement of cell-mediated inflammation in experimental murine autoimmune encephalomyelitis by radioisotopic labeling. J. Immunol. 123, 1799-1805 (1979). (Pubitemid 10188865)
55. Gilliet, M. & Lande, R. Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr. Opin. Immunol. 20, 401-407 (2008).
56. Nijhuis, L. E., Olivier, B. J. & de Jonge, W. J. Neurogenic regulation of dendritic cells in the intestine. Biochem. Pharmacol. 80, 2002-2008 (2010).
57. Tokuyama, H. & Tokuyama, Y. Retinoids enhance IgA production by lipopolysaccharide-stimulated murine spleen cells. Cell. Immunol. 150, 353-363 (1993). (Pubitemid 23290339)
58. Baeke, F., Takiishi, T., Korf, H., Gysemans, C. & Mathieu, C. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10, 482-496 (2010).
59. Wilbanks, G. A., Mammolenti, M. & Streilein, J. W. Studies on the induction of anterior chamberassociated immune deviation (ACAID) III. Induction of ACAID depends upon intraocular transforming growth factor-β. Eur. J. Immunol. 22, 165-173 (1992).
60. Kosiewicz, M. M., Alard, P. & Streilein, J. W. Alterations in cytokine production following intraocular injection of soluble protein antigen: impairment in IFN-γ and induction of TGF-β and IL-4 production. J. Immunol. 161, 5382-5390 (1998). (Pubitemid 28519099)
61. Stavnezer, J. & Kang, J. The surprising discovery that TGFβ specifically induces the IgA class switch. J. Immunol. 182, 5-7 (2009).
62. Penna, G. et al. 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 178, 145-153 (2007). (Pubitemid 46033595)
63. Imai, T. et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol. 11, 81-88 (1999). (Pubitemid 29037591)
64. Lemire, J. M. & Adams, J. S. 1,25-Dihydroxyvitamin D3 inhibits the passive transfer of cellular immunity by a myelin basic protein-specific T cell clone. J. Bone Miner. Res. 7, 171-177 (1992).
65. Cheroutre, H. & Lambolez, F. The thymus chapter in the life of gut-specific intra epithelial lymphocytes. Curr. Opin. Immunol. 20, 185-191 (2008).
66. Groh, V., Steinle, A., Bauer, S. & Spies, T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 279, 1737-1740 (1998). (Pubitemid 28164472)
67. Treiner, E. et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422, 164-169 (2003). (Pubitemid 36362748)
68. Hue, S. et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21, 367-377 (2004). (Pubitemid 39208338)
69. Bendelac, A., Savage, P. B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007). (Pubitemid 46697911)
70. Jameson, J. & Havran, W. L. Skin γδ T-cell functions in homeostasis and wound healing. Immunol. Rev. 215, 114-122 (2007). (Pubitemid 46212234)
71. Boismenu, R. & Havran, W. L. Modulation of epithelial cell growth by intraepithelial γδ T cells. Science 266, 1253-1255 (1994). (Pubitemid 24371285)
72. Boismenu, R., Hobbs, M. V., Boullier, S. & Havran, W. L. Molecular and cellular biology of dendritic epidermal T cells. Semin. Immunol. 8, 323-331 (1996). (Pubitemid 26418370)
73. Braun, A., Wiebe, P., Pfeufer, A., Gessner, R. & Renz, H. Differential modulation of human immunoglobulin isotype production by the neuropeptides substance P, NKA and NKB. J. Neuroimmunol. 97, 43-50 (1999). (Pubitemid 29301412)
74. Dunzendorfer, S. & Wiedermann, C. J. Neuropeptides and the immune system: focus on dendritic cells. Crit. Rev. Immunol. 21, 523-557 (2001). (Pubitemid 34579090)
75. Ho, W. Z., Lai, J. P., Zhu, X. H., Uvaydova, M. & Douglas, S. D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J. Immunol. 159, 5654-5660 (1997). (Pubitemid 127470097)
76. Lai, J. P., Douglas, S. D. & Ho, W. Z. Human lymphocytes express substance P and its receptor. J. Neuroimmunol. 86, 80-86 (1998). (Pubitemid 28293952)
77. Qian, B. F., Zhou, G. Q., Hammarstrom, M. L. & Danielsson, A. Both substance P and its receptor are expressed in mouse intestinal T lymphocytes. Neuroendocrinology 73, 358-368 (2001). (Pubitemid 32588860)
78. Shibata, M., Hisajima, T., Nakano, M., Goris, R. C. & Funakoshi, K. Morphological relationships between peptidergic nerve fibers and immunoglobulin Aproducing lymphocytes in the mouse intestine. Brain Behav. Immun. 22, 158-166 (2008). (Pubitemid 350299812)
79. Meek, B., Speijer, D., de Jong, P. T., de Smet, M. D. & Peek, R. The ocular humoral immune response in health and disease. Prog. Retin. Eye Res. 22, 391-415 (2003). (Pubitemid 38352554)
80. Lausch, R. N., Monteiro, C., Kleinschrodt, W. R. & Oakes, J. E. Superiority of antibody versus delayed hypersensitivity in clearance of HSV-1 from eye. Invest. Ophthalmol. Vis. Sci. 28, 565-570 (1987). (Pubitemid 17040869)
81. Everson, M. P. et al. Dendritic cells from different tissues induce production of different T cell cytokine profiles. J. Leukoc. Biol. 59, 494-498 (1996). (Pubitemid 26156612)
82. Bode, U. et al. Dendritic cell subsets in lymph nodes are characterized by the specific draining area and influence the phenotype and fate of primed T cells. Immunology 123, 480-490 (2008). (Pubitemid 351280962)
83. Iliev, I. D., Mileti, E., Matteoli, G., Chieppa, M. & Rescigno, M. Intestinal epithelial cells promote colitisprotective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol. 2, 340-350 (2009).
84. Rimoldi, M. et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nature Immunol. 6, 507-514 (2005). (Pubitemid 41716764)
85. Xia, S. et al. Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. Blood 112, 3175-3185 (2008).
86. Zeuthen, L. H., Fink, L. N. & Frokiaer, H. Epithelial cells prime the immune response to an array of gutderived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-β. Immunology 123, 197-208 (2008).
87. Kunkel, E. J. et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J. Exp. Med. 192, 761-768 (2000).
88. Iwasaki, A. & Kelsall, B. L. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190, 229-239 (1999). (Pubitemid 29354916)
89. Mora, J. R. et al. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin-and gut-associated lymphoid tissues. J. Exp. Med. 201, 303-316 (2005). (Pubitemid 40189439)
90. Calzascia, T. et al. Homing phenotypes of tumorspecific CD8 T cells are predetermined at the tumor site by crosspresenting APCs. Immunity 22, 175-184 (2005). (Pubitemid 40255709)
91. Alyanakian, M. A. et al. Diversity of regulatory CD4+ T cells controlling distinct organ-specific autoimmune diseases. Proc. Natl Acad. Sci. USA 100, 15806-15811 (2003).
92. Alpan, O., Bachelder, E., Isil, E., Arnheiter, H. & Matzinger, P. 'Educated' dendritic cells act as messengers from memory to naive T helper cells. Nature Immunol. 5, 615-622 (2004). (Pubitemid 38811886)
93. De Smedt, T. et al. Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J. Immunol. 161, 4476-4479 (1998). (Pubitemid 28492014)
94. Helft, J. et al. Antigen-specific T-T interactions regulate CD4 T-cell expansion. Blood 112, 1249-1258 (2008).
95. Martinon, F., Mayor, A. & Tschopp, J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009).
96. Yu, L., Wang, L. & Chen, S. Endogenous Toll-like receptor ligands and their biological significance. J. Cell. Mol. Med. 14, 2592-2603 (2010).
97. Eisenbarth, S. C. et al. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196, 1645-1651 (2002). (Pubitemid 36026476)
98. Belkaid, Y. The role of CD4+CD25+ regulatory T cells in Leishmania infection. Expert Opin. Biol. Ther. 3, 875-885 (2003). (Pubitemid 37093142)
99. Jankovic, D. et al. Conventional T-bet+Foxp3-Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204, 273-283 (2007). (Pubitemid 46294544)
100. Shah, P. D., Gilbertson, S. M. & Rowley, D. A. Dendritic cells that have interacted with antigen are targets for natural killer cells. J. Exp. Med. 162, 625-636 (1985). (Pubitemid 15249964)
101. Sitkovsky, M. & Lukashev, D. Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors. Nature Rev. Immunol. 5, 712-721 (2005). (Pubitemid 43086172)
102. Pulendran, B., Palucka, K. & Banchereau, J. Sensing pathogens and tuning immune responses. Science 293, 253-256 (2001). (Pubitemid 32694733)
103. Takahashi, H. et al. Detection and comparison of viral antigens in measles and rubella rashes. Clin. Infect. Dis. 22, 36-39 (1996). (Pubitemid 26022009)
104. Isa, M. B. et al. Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals. Clin. Diagn. Lab. Immunol. 9, 693-697 (2002). (Pubitemid 34538233)
105. Gonzalez, R., Franco, M., Sarmiento, L., Romero, M. & Schael, I. P. Serum IgA levels induced by rotavirus natural infection, but not following immunization with the RRV-TV vaccine (Rotashield), correlate with protection. J. Med. Virol. 76, 608-612 (2005). (Pubitemid 40943273)
106. Liew, F. Y., Russell, S. M., Appleyard, G., Brand, C. M. & Beale, J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 14, 350-356 (1984). (Pubitemid 14141641)
107. Mora, J. R. et al. Generation of gut-homing IgAsecreting B cells by intestinal dendritic cells. Science 314, 1157-1160 (2006). (Pubitemid 44789048)
108. Fagarasan, S. & Honjo, T. Intestinal IgA synthesis: regulation of front-line body defences. Nature Rev. Immunol. 3, 63-72 (2003). (Pubitemid 37328700)
109. Brandtzaeg, P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 25, 5467-5484 (2007). (Pubitemid 47031365)
110. Amiri, P. et al. Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon γ knockout mice. J. Exp. Med. 180, 43-51 (1994). (Pubitemid 24181054)
111. King, C. L., Malhotra, I. & Jia, X. Schistosoma mansoni: protective immunity in IL-4-deficient mice. Exp. Parasitol. 84, 245-252 (1996). (Pubitemid 26399790)
112. Hogarth, P. J., Folkard, S. G., Taylor, M. J. & Bianco, A. E. Accelerated clearance of Onchocerca microfilariae and resistance to reinfection in interleukin-4 gene knockout mice. Parasite Immunol. 17, 653-657 (1995). (Pubitemid 26043095)
113. Brito, C. F., Caldas, I. R., Coura Filho, P., Correa-Oliveira, R. & Oliveira, S. C. CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-γ and tumour necrosis factor-α in response to the recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein. Scand. J. Immunol. 51, 595-601 (2000). (Pubitemid 30353369)
114. Viana, I. R. et al. Interferon-γ production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg. 88, 466-470 (1994).
115. Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J. & Ploegh, H. L. Viral subversion of the immune system. Annu. Rev. Immunol. 18, 861-926 (2000). (Pubitemid 30365400)
116. Terrazas, C. A., Terrazas, L. I. & Gomez-Garcia, L. Modulation of dendritic cell responses by parasites: a common strategy to survive. J. Biomed. Biotechnol. 2010, 357106 (2010).
117. Thorstenson, K. M. & Khoruts, A. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167, 188-195 (2001). (Pubitemid 32567777)
118. Zhang, X., Izikson, L., Liu, L. & Weiner, H. L. Activation of CD25+CD4+ regulatory T cells by oral antigen administration. J. Immunol. 167, 4245-4253 (2001). (Pubitemid 32954298)
119. Coombes, J. L. et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic aciddependent mechanism. J. Exp. Med. 204, 1757-1764 (2007). (Pubitemid 47236314)
120. Sun, J. B., Raghavan, S., Sjoling, A., Lundin, S. & Holmgren, J. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25-CD4+ regulatory T cells. J. Immunol. 177, 7634-7644 (2006). (Pubitemid 44846278)
121. Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunol. 4, 330-336 (2003). (Pubitemid 36432314)
122. Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775-787 (2008). (Pubitemid 351707693)
123. Shevach, E. M. Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity 30, 636-645 (2009).
124. Shevach, E. M. From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25, 195-201 (2006). (Pubitemid 44224153)
125. Mempel, T. R. et al. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25, 129-141 (2006). (Pubitemid 44066829)
126. Tsuji, M. et al. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 323, 1488-1492 (2009).
127. Cong, Y., Feng, T., Fujihashi, K., Schoeb, T. R. & Elson, C. O. A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota. Proc. Natl Acad. Sci. USA 106, 19256-19261 (2009).
128. Zarember, K. A. & Godowski, P. J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168, 554-561 (2002). (Pubitemid 34049553)
129. Hammad, H. et al. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nature Med. 15, 410-416 (2009).
130. Shearer, J. D., Richards, J. R., Mills, C. D. & Caldwell, M. D. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am. J. Physiol. 272, E181-E190 (1997).
131. Kropf, P. et al. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 19, 1000-1002 (2005). (Pubitemid 40827731)
132. Rogers, M. et al. Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival. PLoS Pathog. 5, e1000555 (2009).
133. Davis, J. M. & Ramakrishnan, L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37-49 (2009).
134. Ulrichs, T. & Kaufmann, S. H. New insights into the function of granulomas in human tuberculosis. J. Pathol. 208, 261-269 (2006). (Pubitemid 43126118)
135. Siciliano, N. A., Skinner, J. A. & Yuk, M. H. Bordetella bronchiseptica modulates macrophage phenotype leading to the inhibition of CD4+ T cell proliferation and the initiation of a Th17 immune response. J. Immunol. 177, 7131-7138 (2006). (Pubitemid 44715081)
136. Everts, B. et al. Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses. J. Exp. Med. 206, 1673-1680 (2009).
137. Steinfelder, S. et al. The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1). J. Exp. Med. 206, 1681-1690 (2009).
138. van der Kleij, D. et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J. Biol. Chem. 277, 48122-48129 (2002).
139. Bergman, M. P. et al. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J. Exp. Med. 200, 979-990 (2004). (Pubitemid 39431123)
140. Meade, R. et al. Transforming growth factor-beta 1 inhibits murine immediate and delayed type hypersensitivity. J. Immunol. 149, 521-528 (1992).
141. Bommireddy, R. & Doetschman, T. TGFβ1 and Treg cells: alliance for tolerance. Trends Mol. Med. 13, 492-501 (2007). (Pubitemid 350086979)
142. Goetzl, E. J. et al. Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide. Proc. Natl Acad. Sci. USA 98, 13854-13859 (2001). (Pubitemid 33115988)
143. Delgado, M., Chorny, A., Gonzalez-Rey, E. & Ganea, D. Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo. J. Leukoc. Biol. 78, 1327-1338 (2005). (Pubitemid 41779239)
144. Taylor, A. W., Yee, D. G., Nishida, T. & Namba, K. Neuropeptide regulation of immunity. The immunosuppressive activity of alpha- melanocytestimulating hormone (α-MSH). Ann. NY Acad. Sci. 917, 239-247 (2000).
145. Taylor, A. W. Modulation of regulatory T cell immunity by the neuropeptide alpha-melanocyte stimulating hormone. Cell. Mol. Biol. 49, 143-149 (2003).
146. Mazzucchelli, R. et al. Development of regulatory T cells requires IL-7Rα stimulation by IL-7 or TSLP. Blood 112, 3283-3292 (2008).
147. He, B. et al. Intestinal bacteria trigger T cellindependent immunoglobulin A2 class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26, 812-826 (2007). (Pubitemid 46915505)
148. Wiedermann, U. et al. Vitamin A deficiency increases inflammatory responses. Scand. J. Immunol. 44, 578-584 (1996). (Pubitemid 26400371)
149. Cantorna, M. T., Nashold, F. E. & Hayes, C. E. Vitamin A deficiency results in a priming environment conducive for Th1 cell development. Eur. J. Immunol. 25, 1673-1679 (1995).
150. Kang, S. G., Lim, H. W., Andrisani, O. M., Broxmeyer, H. E. & Kim, C. H. Vitamin A metabolites induce guthoming FoxP3+ regulatory T cells. J. Immunol. 179, 3724-3733 (2007).
151. Sun, C. M. et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204, 1775-1785 (2007).